Trademark: 87091025
Word
SYNEURX
Status
Registered
Status Code
700
Status Date
Tuesday, March 6, 2018
Serial Number
87091025
Registration Number
5419038
Registration Date
Tuesday, March 6, 2018
Mark Type
5000
Filing Date
Friday, July 1, 2016
Published for Opposition
Tuesday, May 23, 2017

Trademark Owner History
SyneuRx International Corp. - Original Registrant

Classifications
5 Pharmaceutical products and substances for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; medicines for neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; pharmaceutical preparations for neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; sodium salts for medical purposes
42 Pharmaceutical preparations and drug development services for developing drugs for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Biological research; Clinical lab test of medical reagents for conducting clinical trials for others in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Scientific research and analysis in the field of medical reagents; Providing research and development of technology in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Technical research in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Technical project studies in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Scientific laboratory services
The mark consists of the stylized word "SYNEURX".
Color is not claimed as a feature of the mark.

Trademark Events
Mar 6, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Dec 28, 2022
Teas Change Of Correspondence Received
Dec 28, 2022
Teas Change Of Domestic Representatives Address
Dec 28, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 28, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 28, 2022
Teas Change Of Correspondence Received
Dec 28, 2022
Teas Change Of Domestic Representatives Address
Dec 28, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 28, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 23, 2022
Teas Change Of Correspondence Received
Dec 23, 2022
Teas Change Of Domestic Representatives Address
Dec 23, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 23, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 6, 2018
Registered-Principal Register
Jan 31, 2018
Notice Of Acceptance Of Statement Of Use E-Mailed
Jan 30, 2018
Allowed Principal Register - Sou Accepted
Jan 30, 2018
Statement Of Use Processing Complete
Jan 18, 2018
Use Amendment Filed
Jan 30, 2018
Case Assigned To Intent To Use Paralegal
Jan 18, 2018
Teas Statement Of Use Received
Jul 18, 2017
Noa E-Mailed - Sou Required From Applicant
May 23, 2017
Official Gazette Publication Confirmation E-Mailed
May 23, 2017
Published For Opposition
May 3, 2017
Notification Of Notice Of Publication E-Mailed
Apr 14, 2017
Approved For Pub - Principal Register
Apr 1, 2017
Teas/Email Correspondence Entered
Mar 31, 2017
Correspondence Received In Law Office
Mar 31, 2017
Teas Response To Office Action Received
Oct 13, 2016
Notification Of Non-Final Action E-Mailed
Oct 13, 2016
Non-Final Action E-Mailed
Oct 13, 2016
Non-Final Action Written
Oct 12, 2016
Assigned To Examiner
Jul 6, 2016
New Application Office Supplied Data Entered
Jul 5, 2016
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24